US equities
|
MU
$912.74
▲+4.01%
TSLA
$393.93
▲+5.83%
SPCX
$149.57
▲+1.41%
NVDA
$216.06
▲+2.42%
META
$633.02
▼-1.49%
AAPL
$342.90
▼-1.39%
SNDK
$1,273.48
▲+2.86%
INTC
$91.70
▲+5.45%
MU
$912.74
▲+4.01%
TSLA
$393.93
▲+5.83%
SPCX
$149.57
▲+1.41%
NVDA
$216.06
▲+2.42%
META
$633.02
▼-1.49%
AAPL
$342.90
▼-1.39%
SNDK
$1,273.48
▲+2.86%
INTC
$91.70
▲+5.45%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about 5/HT1A Receptor agonist
Recent news which mentions 5/HT1A Receptor agonist
Neurolixis expands rare autism disorders research program
June 04, 2024
Tags
FRAXA
Autism Spectrum Disorder
Medical
From
PRLog